Skip to main content

Aker BioMarine AS (AKBM.OL)

46.8Fair

ValueMarkers Composite Index

Top 21%#35,496 of 44,707
Overvalued

65% above intrinsic value ($6)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-3.10
Low Risk
Altman
1.12
Distress
DCF Value
$6
Overvalued
ROIC
5.4%
Low
P/E
-39.6
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Aker BioMarine AS (AKBM.OL) — VMCI valuation read

Aker BioMarine AS sits at VMCI 47/100, with the broad-market sample median at 50. That 3-point spread is the first thing to note on AKBM.OL: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on AKBM.OL are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on AKBM.OL: AKBM.OL trades at 24.0x earnings, 33% above the sector median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the sector median (10.0%). The Risk read: net debt to EBITDA of -1.4x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

AKBM.OL rose 3.6% over the trailing 7 days, with a -19.7% read on a 30-day basis.

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

CEO: Matts Johansen249 employeesNOwww.akerbiomarine.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in AKBM.OL’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.